iGuard.org has changed its name to MediGuard
Recent Alerts
FDA Makes Changes to Risk Evaluation and Mitigation Strategies (REMS) Program for Nplate (Romiplostim) and Promacta (Eltrombopag)
2012-01-26
The U.S. Food and Drug Administration (FDA) has approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for platelet-booster drugs Nplate (romiplostim) injection and Promacta (eltromb... More
FDA Announces New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) Associated with Tysabri (Natalizumab)
2012-01-24
The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoenceph... More
Rexall, Inc Issues Allergy Alert and Recall of Single Lot of Calcium 1200mg plus Vitamin D 1000 IU Softgels
2012-01-18
Rexall, Inc., of Deerfield Beach, Florida, has announced a recall of Rexall brand Calcium 1200 mg plus 1000 IU Vitamin D3, 60 softgels. The affected bottles actually contain a TABLET product, Triple S... More
New Study Raises Concerns about Daily Aspirin Use in People Without a History of Heart Disease
2012-01-18
A new study published in the Archives of Internal Medicines highlights safety concerns about aspirin use by people without a history of heart disease. The subjects in this study who had never had a he... More
New Boxed Warning for Progressive Multifocal Leukoencephalopathy (PML) and Contraindication for Adcetris (Brentuximab vedotin)
2012-01-16
The U.S. Food and Drug Adminstration has announced that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been... More
See all alerts
Ask Us

